
|Articles|February 15, 2017
Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Advertisement
Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
Abnormal uterine bleeding affects approximately 30% of women. Ultimately, direct visualization via hysteroscopy is known to provide a minimally invasive approach to visualize the endometrial cavity and enable subsequent removal of structural uterine lesions using electrosurgical loop or hysteroscopic morcellation. This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception
2
Natural Cycles receives FDA clearance for AI-powered fertility algorithm
3
New fertility tool to help determine chances of successful IVF launches
4
Endometriosis Risk Factors and the Cost of Chronic Pelvic Pain
5





